Click here for links to My NCBI bibliography and Google Scholar
9919635
XGDAY9JP
1
nature-no-et-al
50
date
desc
Chidley, C.
21
https://sites.duke.edu/chidleylab/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22US2L4VF4%22%2C%22library%22%3A%7B%22id%22%3A9919635%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Conger%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-27%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BConger%2C%20K.%20O.%2C%20%26lt%3Bstrong%26gt%3BChidley%2C%20C.%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Ozgurses%2C%20M.%20E.%2C%20Zhao%2C%20H.%2C%20Kim%2C%20Y.%2C%20Semina%2C%20S.%20E.%2C%20Burns%2C%20P.%2C%20Rawat%2C%20V.%2C%20Lietuvninkas%2C%20L.%2C%20Sheldon%2C%20R.%2C%20Ben-Sahra%2C%20I.%2C%20Frasor%2C%20J.%2C%20Sorger%2C%20P.%20K.%2C%20DeNicola%2C%20G.%20M.%20%26amp%3B%20Coloff%2C%20J.%20L.%20ASCT2%20is%20a%20major%20contributor%20to%20serine%20uptake%20in%20cancer%20cells.%20%26lt%3Bi%26gt%3BCell%20Reports%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bb%26gt%3B43%26lt%3B%5C%2Fb%26gt%3B%2C%20%282024%29.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ASCT2%20is%20a%20major%20contributor%20to%20serine%20uptake%20in%20cancer%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%20O.%22%2C%22lastName%22%3A%22Conger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mete%20Emir%22%2C%22lastName%22%3A%22Ozgurses%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huiping%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yumi%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Svetlana%20E.%22%2C%22lastName%22%3A%22Semina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippa%22%2C%22lastName%22%3A%22Burns%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vipin%22%2C%22lastName%22%3A%22Rawat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lina%22%2C%22lastName%22%3A%22Lietuvninkas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Sheldon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Issam%22%2C%22lastName%22%3A%22Ben-Sahra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonna%22%2C%22lastName%22%3A%22Frasor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gina%20M.%22%2C%22lastName%22%3A%22DeNicola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20L.%22%2C%22lastName%22%3A%22Coloff%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024-08-27%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.celrep.2024.114552%22%2C%22ISSN%22%3A%222211-1247%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.cell.com%5C%2Fcell-reports%5C%2Fabstract%5C%2FS2211-1247%2824%2900881-7%22%2C%22collections%22%3A%5B%22XGDAY9JP%22%5D%2C%22dateModified%22%3A%222024-08-05T00%3A56%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22CV2MDAJH%22%2C%22library%22%3A%7B%22id%22%3A9919635%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Do%20et%20al.%22%2C%22parsedDate%22%3A%222024-05-30%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BDo%2C%20B.%20T.%2C%20Hsu%2C%20P.%20P.%2C%20Vermeulen%2C%20S.%20Y.%2C%20Wang%2C%20Z.%2C%20Hirz%2C%20T.%2C%20Abbott%2C%20K.%20L.%2C%20Aziz%2C%20N.%2C%20Replogle%2C%20J.%20M.%2C%20Bjelosevic%2C%20S.%2C%20Paolino%2C%20J.%2C%20Nelson%2C%20S.%20A.%2C%20Block%2C%20S.%2C%20Darnell%2C%20A.%20M.%2C%20Ferreira%2C%20R.%2C%20Zhang%2C%20H.%2C%20Milosevic%2C%20J.%2C%20Schmidt%2C%20D.%20R.%2C%20%26lt%3Bstrong%26gt%3BChidley%2C%20C.%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Harris%2C%20I.%20S.%2C%20Weissman%2C%20J.%20S.%2C%20Pikman%2C%20Y.%2C%20Stegmaier%2C%20K.%2C%20Cheloufi%2C%20S.%2C%20Su%2C%20X.%20A.%2C%20Sykes%2C%20D.%20B.%20%26amp%3B%20Vander%20Heiden%2C%20M.%20G.%20Nucleotide%20depletion%20promotes%20cell%20fate%20transitions%20by%20inducing%20DNA%20replication%20stress.%20%26lt%3Bi%26gt%3BDev%20Cell%26lt%3B%5C%2Fi%26gt%3B%20S1534-5807%2824%2900327%26%23x2013%3B7%20%282024%29.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Nucleotide%20depletion%20promotes%20cell%20fate%20transitions%20by%20inducing%20DNA%20replication%20stress%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20T.%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peggy%20P.%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sidney%20Y.%22%2C%22lastName%22%3A%22Vermeulen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhishan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taghreed%22%2C%22lastName%22%3A%22Hirz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keene%20L.%22%2C%22lastName%22%3A%22Abbott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Najihah%22%2C%22lastName%22%3A%22Aziz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20M.%22%2C%22lastName%22%3A%22Replogle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Bjelosevic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Paolino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%20A.%22%2C%22lastName%22%3A%22Nelson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Block%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alicia%20M.%22%2C%22lastName%22%3A%22Darnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raphael%22%2C%22lastName%22%3A%22Ferreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanyu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jelena%22%2C%22lastName%22%3A%22Milosevic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20R.%22%2C%22lastName%22%3A%22Schmidt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%20S.%22%2C%22lastName%22%3A%22Harris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20S.%22%2C%22lastName%22%3A%22Weissman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yana%22%2C%22lastName%22%3A%22Pikman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberly%22%2C%22lastName%22%3A%22Stegmaier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sihem%22%2C%22lastName%22%3A%22Cheloufi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaofeng%20A.%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20B.%22%2C%22lastName%22%3A%22Sykes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Vander%20Heiden%22%7D%5D%2C%22abstractNote%22%3A%22Control%20of%20cellular%20identity%20requires%20coordination%20of%20developmental%20programs%20with%20environmental%20factors%20such%20as%20nutrient%20availability%2C%20suggesting%20that%20perturbing%20metabolism%20can%20alter%20cell%20state.%20Here%2C%20we%20find%20that%20nucleotide%20depletion%20and%20DNA%20replication%20stress%20drive%20differentiation%20in%20human%20and%20murine%20normal%20and%20transformed%20hematopoietic%20systems%2C%20including%20patient-derived%20acute%20myeloid%20leukemia%20%28AML%29%20xenografts.%20These%20cell%20state%20transitions%20begin%20during%20S%20phase%20and%20are%20independent%20of%20ATR%5C%2FATM%20checkpoint%20signaling%2C%20double-stranded%20DNA%20break%20formation%2C%20and%20changes%20in%20cell%20cycle%20length.%20In%20systems%20where%20differentiation%20is%20blocked%20by%20oncogenic%20transcription%20factor%20expression%2C%20replication%20stress%20activates%20primed%20regulatory%20loci%20and%20induces%20lineage-appropriate%20maturation%20genes%20despite%20the%20persistence%20of%20progenitor%20programs.%20Altering%20the%20baseline%20cell%20state%20by%20manipulating%20transcription%20factor%20expression%20causes%20replication%20stress%20to%20induce%20genes%20specific%20for%20alternative%20lineages.%20The%20ability%20of%20replication%20stress%20to%20selectively%20activate%20primed%20maturation%20programs%20across%20different%20contexts%20suggests%20a%20general%20mechanism%20by%20which%20changes%20in%20metabolism%20can%20promote%20lineage-appropriate%20cell%20state%20transitions.%22%2C%22date%22%3A%222024-05-30%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221878-1551%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1534580724003277%3Fvia%253Dihub%22%2C%22collections%22%3A%5B%22XGDAY9JP%22%5D%2C%22dateModified%22%3A%222025-05-23T05%3A31%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22N7CX4BWL%22%2C%22library%22%3A%7B%22id%22%3A9919635%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chidley%20et%20al.%22%2C%22parsedDate%22%3A%222024-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BChidley%2C%20C.%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Darnell%2C%20A.%20M.%2C%20Gaudio%2C%20B.%20L.%2C%20Lien%2C%20E.%20C.%2C%20Barbeau%2C%20A.%20M.%2C%20Vander%20Heiden%2C%20M.%20G.%20%26amp%3B%20Sorger%2C%20P.%20K.%20A%20CRISPRi%5C%2Fa%20screening%20platform%20to%20study%20cellular%20nutrient%20transport%20in%20diverse%20microenvironments.%20%26lt%3Bi%26gt%3BNat%20Cell%20Biol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bb%26gt%3B26%26lt%3B%5C%2Fb%26gt%3B%2C%20825%26%23x2013%3B838%20%282024%29.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20CRISPRi%5C%2Fa%20screening%20platform%20to%20study%20cellular%20nutrient%20transport%20in%20diverse%20microenvironments%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alicia%20M.%22%2C%22lastName%22%3A%22Darnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20L.%22%2C%22lastName%22%3A%22Gaudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evan%20C.%22%2C%22lastName%22%3A%22Lien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20M.%22%2C%22lastName%22%3A%22Barbeau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Vander%20Heiden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Blocking%20the%20import%20of%20nutrients%20essential%20for%20cancer%20cell%20proliferation%20represents%20a%20therapeutic%20opportunity%2C%20but%20it%20is%20unclear%20which%20transporters%20to%20target.%20Here%20we%20report%20a%20CRISPR%20interference%5C%2Factivation%20screening%20platform%20to%20systematically%20interrogate%20the%20contribution%20of%20nutrient%20transporters%20to%20support%20cancer%20cell%20proliferation%20in%20environments%20ranging%20from%20standard%20culture%20media%20to%20tumours.%20We%20applied%20this%20platform%20to%20identify%20the%20transporters%20of%20amino%20acids%20in%20leukaemia%20cells%20and%20found%20that%20amino%20acid%20transport%20involves%20high%20bidirectional%20flux%20dependent%20on%20the%20microenvironment%20composition.%20While%20investigating%20the%20role%20of%20transporters%20in%20cystine%20starved%20cells%2C%20we%20uncovered%20a%20role%20for%20serotonin%20uptake%20in%20preventing%20ferroptosis.%20Finally%2C%20we%20identified%20transporters%20essential%20for%20cell%20proliferation%20in%20subcutaneous%20tumours%20and%20found%20that%20levels%20of%20glucose%20and%20amino%20acids%20can%20restrain%20proliferation%20in%20that%20environment.%20This%20study%20establishes%20a%20framework%20for%20systematically%20identifying%20critical%20cellular%20nutrient%20transporters%2C%20characterizing%20their%20function%20and%20exploring%20how%20the%20tumour%20microenvironment%20impacts%20cancer%20metabolism.%22%2C%22date%22%3A%222024-05%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41556-024-01402-1%22%2C%22ISSN%22%3A%221476-4679%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41556-024-01402-1%22%2C%22collections%22%3A%5B%22XGDAY9JP%22%5D%2C%22dateModified%22%3A%222024-07-10T21%3A24%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22FF8RH5P3%22%2C%22library%22%3A%7B%22id%22%3A9919635%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Qian%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-20%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BQian%2C%20J.%2C%20Boswell%2C%20S.%20A.%2C%20%26lt%3Bstrong%26gt%3BChidley%2C%20C.%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Lu%2C%20Z.-X.%2C%20Pettit%2C%20M.%20E.%2C%20Gaudio%2C%20B.%20L.%2C%20Fajnzylber%2C%20J.%20M.%2C%20Ingram%2C%20R.%20T.%2C%20Ward%2C%20R.%20H.%2C%20Li%2C%20J.%20Z.%20%26amp%3B%20Springer%2C%20M.%20An%20enhanced%20isothermal%20amplification%20assay%20for%20viral%20detection.%20%26lt%3Bi%26gt%3BNat%20Commun%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bb%26gt%3B11%26lt%3B%5C%2Fb%26gt%3B%2C%205920%20%282020%29.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20enhanced%20isothermal%20amplification%20assay%20for%20viral%20detection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhi-Xiang%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20E.%22%2C%22lastName%22%3A%22Pettit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20L.%22%2C%22lastName%22%3A%22Gaudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jesse%20M.%22%2C%22lastName%22%3A%22Fajnzylber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%20T.%22%2C%22lastName%22%3A%22Ingram%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%20H.%22%2C%22lastName%22%3A%22Ward%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20Z.%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Springer%22%7D%5D%2C%22abstractNote%22%3A%22Rapid%2C%20inexpensive%2C%20robust%20diagnostics%20are%20essential%20to%20control%20the%20spread%20of%20infectious%20diseases.%20Current%20state%20of%20the%20art%20diagnostics%20are%20highly%20sensitive%20and%20specific%2C%20but%20slow%2C%20and%20require%20expensive%20equipment.%20Here%20we%20report%20the%20development%20of%20a%20molecular%20diagnostic%20test%20for%20SARS-CoV-2%20based%20on%20an%20enhanced%20recombinase%20polymerase%20amplification%20%28eRPA%29%20reaction.%20eRPA%20has%20a%20detection%20limit%20on%20patient%20samples%20down%20to%205%20viral%20copies%2C%20requires%20minimal%20instrumentation%2C%20and%20is%20highly%20scalable%20and%20inexpensive.%20eRPA%20does%20not%20cross-react%20with%20other%20common%20coronaviruses%2C%20does%20not%20require%20RNA%20purification%2C%20and%20takes%20~45%5Cu2009min%20from%20sample%20collection%20to%20results.%20eRPA%20represents%20a%20first%20step%20toward%20at-home%20SARS-CoV-2%20detection%20and%20can%20be%20adapted%20to%20future%20viruses%20within%20days%20of%20genomic%20sequence%20availability.%22%2C%22date%22%3A%222020-11-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-020-19258-y%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41467-020-19258-y%22%2C%22collections%22%3A%5B%22XGDAY9JP%22%5D%2C%22dateModified%22%3A%222025-05-23T05%3A22%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22CTBKI6F7%22%2C%22library%22%3A%7B%22id%22%3A9919635%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gerosa%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-18%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BGerosa%2C%20L.%2C%20%26lt%3Bstrong%26gt%3BChidley%2C%20C.%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Fr%26%23xF6%3Bhlich%2C%20F.%2C%20Sanchez%2C%20G.%2C%20Lim%2C%20S.%20K.%2C%20Muhlich%2C%20J.%2C%20Chen%2C%20J.-Y.%2C%20Vallabhaneni%2C%20S.%2C%20Baker%2C%20G.%20J.%2C%20Schapiro%2C%20D.%2C%20Atanasova%2C%20M.%20I.%2C%20Chylek%2C%20L.%20A.%2C%20Shi%2C%20T.%2C%20Yi%2C%20L.%2C%20Nicora%2C%20C.%20D.%2C%20Claas%2C%20A.%2C%20Ng%2C%20T.%20S.%20C.%2C%20Kohler%2C%20R.%20H.%2C%20Lauffenburger%2C%20D.%20A.%2C%20Weissleder%2C%20R.%2C%20Miller%2C%20M.%20A.%2C%20Qian%2C%20W.-J.%2C%20Wiley%2C%20H.%20S.%20%26amp%3B%20Sorger%2C%20P.%20K.%20Receptor-Driven%20ERK%20Pulses%20Reconfigure%20MAPK%20Signaling%20and%20Enable%20Persistence%20of%20Drug-Adapted%20BRAF-Mutant%20Melanoma%20Cells.%20%26lt%3Bi%26gt%3BCell%20Syst%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bb%26gt%3B11%26lt%3B%5C%2Fb%26gt%3B%2C%20478-494.e9%20%282020%29.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Receptor-Driven%20ERK%20Pulses%20Reconfigure%20MAPK%20Signaling%20and%20Enable%20Persistence%20of%20Drug-Adapted%20BRAF-Mutant%20Melanoma%20Cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luca%22%2C%22lastName%22%3A%22Gerosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabian%22%2C%22lastName%22%3A%22Fr%5Cu00f6hlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Sanchez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sang%20Kyun%22%2C%22lastName%22%3A%22Lim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Yun%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sreeram%22%2C%22lastName%22%3A%22Vallabhaneni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariya%20I.%22%2C%22lastName%22%3A%22Atanasova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lily%20A.%22%2C%22lastName%22%3A%22Chylek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tujin%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lian%22%2C%22lastName%22%3A%22Yi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carrie%20D.%22%2C%22lastName%22%3A%22Nicora%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%22%2C%22lastName%22%3A%22Claas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20S.%20C.%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rainer%20H.%22%2C%22lastName%22%3A%22Kohler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20A.%22%2C%22lastName%22%3A%22Lauffenburger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ralph%22%2C%22lastName%22%3A%22Weissleder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miles%20A.%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei-Jun%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20Steven%22%2C%22lastName%22%3A%22Wiley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Targeted%20inhibition%20of%20oncogenic%20pathways%20can%20be%20highly%20effective%20in%20halting%20the%20rapid%20growth%20of%20tumors%20but%20often%20leads%20to%20the%20emergence%20of%20slowly%20dividing%20persister%20cells%2C%20which%20constitute%20a%20reservoir%20for%20the%20selection%20of%20drug-resistant%20clones.%20In%20BRAFV600E%20melanomas%2C%20RAF%20and%20MEK%20inhibitors%20efficiently%20block%20oncogenic%20signaling%2C%20but%20persister%20cells%20emerge.%20Here%2C%20we%20show%20that%20persister%20cells%20escape%20drug-induced%20cell-cycle%20arrest%20via%20brief%2C%20sporadic%20ERK%20pulses%20generated%20by%20transmembrane%20receptors%20and%20growth%20factors%20operating%20in%20an%20autocrine%5C%2Fparacrine%20manner.%20Quantitative%20proteomics%20and%20computational%20modeling%20show%20that%20ERK%20pulsing%20is%20enabled%20by%20rewiring%20of%20mitogen-activated%20protein%20kinase%20%28MAPK%29%20signaling%3A%20from%20an%20oncogenic%20BRAFV600E%20monomer-driven%20configuration%20that%20is%20drug%20sensitive%20to%20a%20receptor-driven%20configuration%20that%20involves%20Ras-GTP%20and%20RAF%20dimers%20and%20is%20highly%20resistant%20to%20RAF%20and%20MEK%20inhibitors.%20Altogether%2C%20this%20work%20shows%20that%20pulsatile%20MAPK%20activation%20by%20factors%20in%20the%20microenvironment%20generates%20a%20persistent%20population%20of%20melanoma%20cells%20that%20rewires%20MAPK%20signaling%20to%20sustain%20non-genetic%20drug%20resistance.%22%2C%22date%22%3A%222020-11-18%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%222405-4720%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS2405471220303707%3Fvia%253Dihub%22%2C%22collections%22%3A%5B%22GRVP56TN%22%2C%22XGDAY9JP%22%5D%2C%22dateModified%22%3A%222025-05-23T05%3A46%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22M7TJK3S5%22%2C%22library%22%3A%7B%22id%22%3A9919635%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Palmer%20et%20al.%22%2C%22parsedDate%22%3A%222019-11-19%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BPalmer%2C%20A.%20C.%2C%20%26lt%3Bstrong%26gt%3BChidley%2C%20C.%26lt%3B%5C%2Fstrong%26gt%3B%20%26amp%3B%20Sorger%2C%20P.%20K.%20A%20curative%20combination%20cancer%20therapy%20achieves%20high%20fractional%20cell%20killing%20through%20low%20cross-resistance%20and%20drug%20additivity.%20%26lt%3Bi%26gt%3BeLife%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bb%26gt%3B8%26lt%3B%5C%2Fb%26gt%3B%2C%20e50036%20%282019%29.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20curative%20combination%20cancer%20therapy%20achieves%20high%20fractional%20cell%20killing%20through%20low%20cross-resistance%20and%20drug%20additivity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Charles%20L%22%2C%22lastName%22%3A%22Sawyers%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Franco%22%7D%5D%2C%22abstractNote%22%3A%22Curative%20cancer%20therapies%20are%20uncommon%20and%20nearly%20always%20involve%20multi-drug%20combinations%20developed%20by%20experimentation%20in%20humans%3B%20unfortunately%2C%20the%20mechanistic%20basis%20for%20the%20success%20of%20such%20combinations%20has%20rarely%20been%20investigated%20in%20detail%2C%20obscuring%20lessons%20learned.%20Here%2C%20we%20use%20isobologram%20analysis%20to%20score%20pharmacological%20interaction%2C%20and%20clone%20tracing%20and%20CRISPR%20screening%20to%20measure%20cross-resistance%20among%20the%20five%20drugs%20comprising%20R-CHOP%2C%20a%20combination%20therapy%20that%20frequently%20cures%20Diffuse%20Large%20B-Cell%20Lymphomas.%20We%20find%20that%20drugs%20in%20R-CHOP%20exhibit%20very%20low%20cross-resistance%20but%20not%20synergistic%20interaction%3A%20together%20they%20achieve%20a%20greater%20fractional%20kill%20according%20to%20the%20null%20hypothesis%20for%20both%20the%20Loewe%20dose-additivity%20model%20and%20the%20Bliss%20effect-independence%20model.%20These%20data%20provide%20direct%20evidence%20for%20the%2050%20year%20old%20hypothesis%20that%20a%20curative%20cancer%20therapy%20can%20be%20constructed%20on%20the%20basis%20of%20independently%20effective%20drugs%20having%20non-overlapping%20mechanisms%20of%20resistance%2C%20without%20synergistic%20interaction%2C%20which%20has%20immediate%20significance%20for%20the%20design%20of%20new%20drug%20combinations.%22%2C%22date%22%3A%22November%2019%2C%202019%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.50036%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7554%5C%2FeLife.50036%22%2C%22collections%22%3A%5B%22GRVP56TN%22%2C%22XGDAY9JP%22%5D%2C%22dateModified%22%3A%222021-09-09T20%3A19%3A44Z%22%7D%7D%2C%7B%22key%22%3A%227QF778RE%22%2C%22library%22%3A%7B%22id%22%3A9919635%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chidley%20et%20al.%22%2C%22parsedDate%22%3A%222016-07-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BChidley%2C%20C.%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Trauger%2C%20S.%20A.%2C%20Birsoy%2C%20K.%20%26amp%3B%20O%26%23x2019%3BShea%2C%20E.%20K.%20The%20anticancer%20natural%20product%20ophiobolin%20A%20induces%20cytotoxicity%20by%20covalent%20modification%20of%20phosphatidylethanolamine.%20%26lt%3Bi%26gt%3BeLife%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bb%26gt%3B5%26lt%3B%5C%2Fb%26gt%3B%2C%20e14601%20%282016%29.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20anticancer%20natural%20product%20ophiobolin%20A%20induces%20cytotoxicity%20by%20covalent%20modification%20of%20phosphatidylethanolamine%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunia%20A%22%2C%22lastName%22%3A%22Trauger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K%5Cu0131van%5Cu00e7%22%2C%22lastName%22%3A%22Birsoy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%20K%22%2C%22lastName%22%3A%22O%27Shea%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Philip%20A%22%2C%22lastName%22%3A%22Cole%22%7D%5D%2C%22abstractNote%22%3A%22Phenotypic%20screens%20allow%20the%20identification%20of%20small%20molecules%20with%20promising%20anticancer%20activity%2C%20but%20the%20difficulty%20in%20characterizing%20the%20mechanism%20of%20action%20of%20these%20compounds%20in%20human%20cells%20often%20undermines%20their%20value%20as%20drug%20leads.%20Here%2C%20we%20used%20a%20loss-of-function%20genetic%20screen%20in%20human%20haploid%20KBM7%20cells%20to%20discover%20the%20mechanism%20of%20action%20of%20the%20anticancer%20natural%20product%20ophiobolin%20A%20%28OPA%29.%20We%20found%20that%20genetic%20inactivation%20of%20de%20novo%20synthesis%20of%20phosphatidylethanolamine%20%28PE%29%20mitigates%20OPA%20cytotoxicity%20by%20reducing%20cellular%20PE%20levels.%20OPA%20reacts%20with%20the%20ethanolamine%20head%20group%20of%20PE%20in%20human%20cells%20to%20form%20pyrrole-containing%20covalent%20cytotoxic%20adducts%20and%20these%20adducts%20lead%20to%20lipid%20bilayer%20destabilization.%20Our%20characterization%20of%20this%20unusual%20cytotoxicity%20mechanism%2C%20made%20possible%20by%20unbiased%20genetic%20screening%20in%20human%20cells%2C%20suggests%20that%20the%20selective%20antitumor%20activity%20displayed%20by%20OPA%20may%20be%20due%20to%20altered%20membrane%20PE%20levels%20in%20cancer%20cells.%22%2C%22date%22%3A%22July%2012%2C%202016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.14601%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7554%5C%2FeLife.14601%22%2C%22collections%22%3A%5B%22XGDAY9JP%22%5D%2C%22dateModified%22%3A%222021-09-09T20%3A22%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22AJKU63ED%22%2C%22library%22%3A%7B%22id%22%3A9919635%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chidley%20et%20al.%22%2C%22parsedDate%22%3A%222011-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BChidley%2C%20C.%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Haruki%2C%20H.%2C%20Pedersen%2C%20M.%20G.%2C%20Muller%2C%20E.%20%26amp%3B%20Johnsson%2C%20K.%20A%20yeast-based%20screen%20reveals%20that%20sulfasalazine%20inhibits%20tetrahydrobiopterin%20biosynthesis.%20%26lt%3Bi%26gt%3BNat%20Chem%20Biol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bb%26gt%3B7%26lt%3B%5C%2Fb%26gt%3B%2C%20375%26%23x2013%3B383%20%282011%29.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20yeast-based%20screen%20reveals%20that%20sulfasalazine%20inhibits%20tetrahydrobiopterin%20biosynthesis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hirohito%22%2C%22lastName%22%3A%22Haruki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%20Gr%5Cu00f8nlund%22%2C%22lastName%22%3A%22Pedersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evelyne%22%2C%22lastName%22%3A%22Muller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Johnsson%22%7D%5D%2C%22abstractNote%22%3A%22We%20introduce%20an%20approach%20for%20detection%20of%20drug-protein%20interactions%20that%20combines%20a%20new%20yeast%20three-hybrid%20screening%20for%20identification%20of%20interactions%20with%20affinity%20chromatography%20for%20their%20unambiguous%20validation.%20We%20applied%20the%20methodology%20to%20the%20profiling%20of%20clinically%20approved%20drugs%2C%20resulting%20in%20the%20identification%20of%20previously%20known%20and%20unknown%20drug-protein%20interactions.%20In%20particular%2C%20we%20were%20able%20to%20identify%20off-targets%20for%20erlotinib%20and%20atorvastatin%2C%20as%20well%20as%20an%20enzyme%20target%20for%20the%20anti-inflammatory%20drug%20sulfasalazine.%20We%20demonstrate%20that%20sulfasalazine%20and%20its%20metabolites%2C%20sulfapyridine%20and%20mesalamine%2C%20are%20inhibitors%20of%20the%20enzyme%20catalyzing%20the%20final%20step%20in%20the%20biosynthesis%20of%20the%20cofactor%20tetrahydrobiopterin.%20The%20interference%20with%20tetrahydrobiopterin%20metabolism%20provides%20an%20explanation%20for%20some%20of%20the%20beneficial%20and%20deleterious%20properties%20of%20sulfasalazine%20and%20furthermore%20suggests%20new%20and%20improved%20therapies%20for%20the%20drug.%20This%20work%20thus%20establishes%20a%20powerful%20approach%20for%20drug%20profiling%20and%20provides%20new%20insights%20in%20the%20mechanism%20of%20action%20of%20clinically%20approved%20drugs.%22%2C%22date%22%3A%222011-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fnchembio.557%22%2C%22ISSN%22%3A%221552-4469%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fnchembio.557%22%2C%22collections%22%3A%5B%22XGDAY9JP%22%5D%2C%22dateModified%22%3A%222025-05-23T05%3A32%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22E6DJSG92%22%2C%22library%22%3A%7B%22id%22%3A9919635%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chidley%20et%20al.%22%2C%22parsedDate%22%3A%222011%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BChidley%2C%20C.%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Haruki%2C%20H.%2C%20Pedersen%2C%20M.%20G.%2C%20Fellay%2C%20C.%2C%20Moser%2C%20S.%20%26amp%3B%20Johnsson%2C%20K.%20Searching%20for%20the%20protein%20targets%20of%20bioactive%20molecules.%20%26lt%3Bi%26gt%3BChimia%20%28Aarau%29%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bb%26gt%3B65%26lt%3B%5C%2Fb%26gt%3B%2C%20720%26%23x2013%3B724%20%282011%29.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Searching%20for%20the%20protein%20targets%20of%20bioactive%20molecules%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hirohito%22%2C%22lastName%22%3A%22Haruki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%20Gr%5Cu00f8nlund%22%2C%22lastName%22%3A%22Pedersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cindy%22%2C%22lastName%22%3A%22Fellay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%22%2C%22lastName%22%3A%22Moser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Johnsson%22%7D%5D%2C%22abstractNote%22%3A%22The%20identification%20of%20all%20protein%20targets%20of%20a%20given%20drug%20or%20bioactive%20molecule%20within%20the%20human%20body%20is%20a%20prerequisite%20for%20an%20understanding%20of%20its%20beneficial%20and%20deleterious%20activities.%20Current%20approaches%20to%20reveal%20protein%20targets%20often%20fail%20to%20reveal%20physiologically%20relevant%20interactions.%20Here%20we%20review%20a%20recently%20introduced%20yeast-based%20approach%20for%20the%20identification%20of%20the%20binding%20partners%20of%20small%20molecules.%20We%20discuss%20the%20advantages%20and%20limitations%20of%20the%20approach%20using%20the%20clinically%20approved%20drug%20sulfasalazine%20as%20an%20example.%22%2C%22date%22%3A%222011%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2533%5C%2Fchimia.2011.720%22%2C%22ISSN%22%3A%220009-4293%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.chimia.ch%5C%2Fchimia%5C%2Farticle%5C%2Fview%5C%2F2011_720%22%2C%22collections%22%3A%5B%22XGDAY9JP%22%5D%2C%22dateModified%22%3A%222025-05-23T05%3A33%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22SEYQFNA9%22%2C%22library%22%3A%7B%22id%22%3A9919635%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chidley%20et%20al.%22%2C%22parsedDate%22%3A%222008-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BChidley%2C%20C.%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Mosiewicz%2C%20K.%20%26amp%3B%20Johnsson%2C%20K.%20A%20designed%20protein%20for%20the%20specific%20and%20covalent%20heteroconjugation%20of%20biomolecules.%20%26lt%3Bi%26gt%3BBioconjug%20Chem%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bb%26gt%3B19%26lt%3B%5C%2Fb%26gt%3B%2C%201753%26%23x2013%3B1756%20%282008%29.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20designed%20protein%20for%20the%20specific%20and%20covalent%20heteroconjugation%20of%20biomolecules%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katarzyna%22%2C%22lastName%22%3A%22Mosiewicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Johnsson%22%7D%5D%2C%22abstractNote%22%3A%22Bioconjugations%20often%20rely%20on%20adaptor%20molecules%20to%20cross-link%20different%20biomolecules.%20In%20this%20work%2C%20we%20introduce%20the%20molecular%20adaptor%20covalin%2C%20which%20is%20a%20protein%20chimera%20of%20two%20self-labeling%20proteins%20with%20nonoverlapping%20substrate%20specificity.%20Covalin%20permits%20a%20selective%20and%20covalent%20heteroconjugation%20of%20biomolecules%20displaying%20appropriate%20functional%20groups.%20Examples%20for%20the%20use%20of%20covalin%20include%20the%20specific%20heteroconjugation%20of%20a%20reporter%20enzyme%20to%20an%20antibody%20and%20of%20molecular%20probes%20to%20the%20surface%20of%20living%20cells.%20The%20efficiency%20and%20specificity%20of%20covalin-based%20bioconjugations%20together%20with%20the%20availability%20of%20a%20large%20variety%20of%20substrates%20create%20immediate%20and%20ubiquitous%20applications%20for%20covalin%20in%20bioconjugate%20chemistry.%22%2C%22date%22%3A%222008-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Fbc800268j%22%2C%22ISSN%22%3A%221520-4812%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpubs.acs.org%5C%2Fdoi%5C%2F10.1021%5C%2Fbc800268j%22%2C%22collections%22%3A%5B%22XGDAY9JP%22%5D%2C%22dateModified%22%3A%222025-05-23T05%3A32%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22XE6RRQCZ%22%2C%22library%22%3A%7B%22id%22%3A9919635%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gronemeyer%20et%20al.%22%2C%22parsedDate%22%3A%222006-07%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BGronemeyer%2C%20T.%2C%20%26lt%3Bstrong%26gt%3BChidley%2C%20C.%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Juillerat%2C%20A.%2C%20Heinis%2C%20C.%20%26amp%3B%20Johnsson%2C%20K.%20Directed%20evolution%20of%20O6-alkylguanine-DNA%20alkyltransferase%20for%20applications%20in%20protein%20labeling.%20%26lt%3Bi%26gt%3BProtein%20Eng%20Des%20Sel%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bb%26gt%3B19%26lt%3B%5C%2Fb%26gt%3B%2C%20309%26%23x2013%3B316%20%282006%29.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Directed%20evolution%20of%20O6-alkylguanine-DNA%20alkyltransferase%20for%20applications%20in%20protein%20labeling%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Gronemeyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Juillerat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Heinis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Johnsson%22%7D%5D%2C%22abstractNote%22%3A%22The%20specific%20reaction%20of%20O6-alkylguanine-DNA%20alkyltransferase%20%28AGT%29%20with%20O6-benzylguanine%20%28BG%29%20derivatives%20allows%20for%20a%20specific%20labeling%20of%20AGT%20fusion%20proteins%20with%20chemically%20diverse%20compounds%20in%20living%20cells%20and%20in%20vitro.%20The%20efficiency%20of%20the%20labeling%20depends%20on%20a%20number%20of%20factors%2C%20most%20importantly%20on%20the%20reactivity%2C%20selectivity%20and%20stability%20of%20AGT.%20Here%2C%20we%20report%20the%20use%20of%20directed%20evolution%20and%20two%20different%20selection%20systems%20to%20further%20increase%20the%20activity%20of%20AGT%20towards%20BG%20derivatives%20by%20a%20factor%20of%2017%20and%20demonstrate%20the%20advantages%20of%20this%20mutant%20for%20the%20specific%20labeling%20of%20AGT%20fusion%20proteins%20displayed%20on%20the%20surface%20of%20mammalian%20cells.%20The%20results%20furthermore%20identify%20two%20regions%20of%20the%20protein%20outside%20the%20active%20site%20that%20influence%20the%20activity%20of%20the%20protein%20towards%20BG%20derivatives.%22%2C%22date%22%3A%222006-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fprotein%5C%2Fgzl014%22%2C%22ISSN%22%3A%221741-0126%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fpeds%5C%2Farticle%5C%2F19%5C%2F7%5C%2F309%5C%2F1557519%22%2C%22collections%22%3A%5B%22XGDAY9JP%22%5D%2C%22dateModified%22%3A%222025-05-23T05%3A30%3A38Z%22%7D%7D%5D%7D
1.
Conger, K. O., Chidley, C., Ozgurses, M. E., Zhao, H., Kim, Y., Semina, S. E., Burns, P., Rawat, V., Lietuvninkas, L., Sheldon, R., Ben-Sahra, I., Frasor, J., Sorger, P. K., DeNicola, G. M. & Coloff, J. L. ASCT2 is a major contributor to serine uptake in cancer cells. Cell Reports 43, (2024).
1.
Do, B. T., Hsu, P. P., Vermeulen, S. Y., Wang, Z., Hirz, T., Abbott, K. L., Aziz, N., Replogle, J. M., Bjelosevic, S., Paolino, J., Nelson, S. A., Block, S., Darnell, A. M., Ferreira, R., Zhang, H., Milosevic, J., Schmidt, D. R., Chidley, C., Harris, I. S., Weissman, J. S., Pikman, Y., Stegmaier, K., Cheloufi, S., Su, X. A., Sykes, D. B. & Vander Heiden, M. G. Nucleotide depletion promotes cell fate transitions by inducing DNA replication stress. Dev Cell S1534-5807(24)00327–7 (2024).
1.
Chidley, C., Darnell, A. M., Gaudio, B. L., Lien, E. C., Barbeau, A. M., Vander Heiden, M. G. & Sorger, P. K. A CRISPRi/a screening platform to study cellular nutrient transport in diverse microenvironments. Nat Cell Biol 26, 825–838 (2024).
1.
Qian, J., Boswell, S. A., Chidley, C., Lu, Z.-X., Pettit, M. E., Gaudio, B. L., Fajnzylber, J. M., Ingram, R. T., Ward, R. H., Li, J. Z. & Springer, M. An enhanced isothermal amplification assay for viral detection. Nat Commun 11, 5920 (2020).
1.
Gerosa, L., Chidley, C., Fröhlich, F., Sanchez, G., Lim, S. K., Muhlich, J., Chen, J.-Y., Vallabhaneni, S., Baker, G. J., Schapiro, D., Atanasova, M. I., Chylek, L. A., Shi, T., Yi, L., Nicora, C. D., Claas, A., Ng, T. S. C., Kohler, R. H., Lauffenburger, D. A., Weissleder, R., Miller, M. A., Qian, W.-J., Wiley, H. S. & Sorger, P. K. Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells. Cell Syst 11, 478-494.e9 (2020).
1.
Palmer, A. C., Chidley, C. & Sorger, P. K. A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity. eLife 8, e50036 (2019).
1.
Chidley, C., Trauger, S. A., Birsoy, K. & O’Shea, E. K. The anticancer natural product ophiobolin A induces cytotoxicity by covalent modification of phosphatidylethanolamine. eLife 5, e14601 (2016).
1.
Chidley, C., Haruki, H., Pedersen, M. G., Muller, E. & Johnsson, K. A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis. Nat Chem Biol 7, 375–383 (2011).
1.
Chidley, C., Haruki, H., Pedersen, M. G., Fellay, C., Moser, S. & Johnsson, K. Searching for the protein targets of bioactive molecules. Chimia (Aarau) 65, 720–724 (2011).
1.
Chidley, C., Mosiewicz, K. & Johnsson, K. A designed protein for the specific and covalent heteroconjugation of biomolecules. Bioconjug Chem 19, 1753–1756 (2008).
1.
Gronemeyer, T., Chidley, C., Juillerat, A., Heinis, C. & Johnsson, K. Directed evolution of O6-alkylguanine-DNA alkyltransferase for applications in protein labeling. Protein Eng Des Sel 19, 309–316 (2006).
